Crawford Fund Management, LLC Adaptive Biotechnologies Corp Put Options Transaction History

Crawford Fund Management, LLC

  • $466 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.37 - $5.12 $92,675 - $140,800
-27,500 Reduced 67.9%
13,000 $66.6 Million
Q2 2024

Aug 14, 2024
SELL
$2.34 - $3.96 $167,310 - $283,140
-71,500 Reduced 63.84%
40,500 $147 Million
Q1 2024

May 15, 2024
BUY
$2.88 - $4.8 $119,520 - $199,200
41,500 Added 58.87%
112,000 $360 Million
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $243,930 - $375,765
70,500 New
70,500 $345 Million

Others Institutions Holding ADPT

# of Institutions
201
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Crawford Fund Management, LLC Portfolio

Follow Crawford Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email